在高血压中内皮功能生物标志物
Panayotis K Vlachakis1, Panagiotis Theofilis1, Efstathios Manios2
11st Department of Cardiology, "Hippokration" General Hospital, National and Kapodistrian University of Athens, 11527Athens, Greece.
Current medicinal chemistry
|May 6, 2025
概括
高血压 (HTN) 是主要的死亡原因,由内皮功能障碍驱动. 血液和成像中的生物标志物可以早期检测出这种功能障碍,帮助诊断和治疗心血管疾病的策略.
科学领域:
- 心血管医学 心血管医学
- 生物标志物研究 生物标志物研究
- 高血压病理生理学 高血压病理生理学
背景情况:
- 高血压 (HTN) 是一个关键的心血管风险因素,每年导致数百万人的死亡.
- HTN的病理生理学涉及复杂的机制,特别是内皮功能障碍,其特点是血管活性物质的失衡和炎症.
- 早期发现HTN及其并发症对于有效管理和预防长期不良结果至关重要.
研究的目的:
- 探索内皮功能生物标志物在高血压的早期检测和理解中的作用.
- 确定基于血液和成像的关键生物标志物,表明HTN中的内皮功能障碍.
- 评估这些生物标志物的潜力,以指导高血压患者的诊断和治疗策略.
主要方法:
- 对与高血压中的内皮功能障碍相关的生物标志物的现有文献的综述.
- 鉴定血液衍生生物标记物,如氧化 (NO),非对称二甲基氨酸 (ADMA),矩阵金属蛋白酶 (MMP),VCAM-1,ICAM-1和内皮微粒.
- 包括基于成像的生物标志物,如流介导扩张 (FMD) 和冠状动脉流量储备 (CFR).
主要成果:
- 内皮功能障碍是HTN的核心特征,导致血压升高和血管损伤.
- 在HTN中,各种血液和成像生物标志物可以有效地表明炎症,内皮功能障碍和血管损伤.
- 这些生物标志物与血压测量一起,增强了早期诊断,并提供了对疾病机制的见解.
结论:
- 内皮功能生物标志物对高血压的早期检测和改善管理具有显著的前景.
- 需要进一步的大规模前性研究,以充分验证这些生物标志物,以便广泛临床应用.
- 生物标志物分析与血压监测的整合可以完善诊断准确性,并个性化心血管疾病的治疗方法.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
01:18Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
376
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
01:17Hormonal Regulation of Blood Pressure
2.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.2K